Open access peer-reviewed chapter

Is Anticancer Vaccine Possible: Experimental Application of Produced mRNA Transfected Dendritic Cells Derived from Enriched CD34+ Blood Progenitor Cells

By Paula Lazarova, Gunnar Kvalheim and Krassimir Metodiev

Reviewed: July 12th 2012Published: October 10th 2012

DOI: 10.5772/51544

Downloaded: 1639

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Paula Lazarova, Gunnar Kvalheim and Krassimir Metodiev (October 10th 2012). Is Anticancer Vaccine Possible: Experimental Application of Produced mRNA Transfected Dendritic Cells Derived from Enriched CD34+ Blood Progenitor Cells, Immunodeficiency, Krassimir Metodiev, IntechOpen, DOI: 10.5772/51544. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/immunodeficiency/is-anticancer-vaccine-possible-experimental-application-of-produced-mrna-transfected-dendritic-cells" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1639total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Immunoglobulin Treatment of Immunodeficient Patients

By Yıldız Camcıoğlu

Related Book

First chapter

Immunotherapy of Cancer — Some Up-To-Date Approaches

By Krassimir Metodiev, Paula Lazarova, Jon Kyte, Gunnar Kvalheim and Jahn Nesland

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us